UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057802 |
|---|---|
| Receipt number | R000066059 |
| Scientific Title | Disease awareness and perspective of secondary immunodeficiency in Japanese physician -a web-based survey |
| Date of disclosure of the study information | 2025/05/08 |
| Last modified on | 2025/05/08 19:06:32 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Disease awareness and perspective of secondary immunodeficiency in Japanese physician -a web-based survey
Acronym
Disease awareness and perspective of secondary immunodeficiency in Japanese physician -a web-based survey
Scientific Title
Disease awareness and perspective of secondary immunodeficiency in Japanese physician -a web-based survey
Scientific Title:Acronym
Disease awareness and perspective of secondary immunodeficiency in Japanese physician -a web-based survey
Region
| Japan |
Condition
Condition
Secondary immunodeficiency
Classification by specialty
| Medicine in general | Hematology and clinical oncology | Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To elucidate the level of disease awareness and perspective of SID practice among hematologists and infectious disease experts and internists in Japan.
Basic objectives2
Others
Basic objectives -Others
To elucidate the awareness and understanding of the treatment options for SID, and physician's clinical evaluation, diagnosis and management flow and treatment of SID.
Trial characteristics_1
Exploratory
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
The level of disease awareness and perspective of SID practice.(At the time of web survey)
Key secondary outcomes
Treatment options, clinical evaluation, diagnosis, standard of care and management flow of SID. (At the time of web survey)
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Physicians in hematology, general internal medicine and infectious diseases departments who practice hematological diseases
Key exclusion criteria
･Physicians who have less than 3 years of practice excluding training period
･Physicians who work in a facility other than clinics, university hospitals, national and public hospitals, or public medical institutions/private hospitals
･Physicians who currently treating zero/none outpatients and inpatients
･Physicians who are related to Takeda and/or the Contract Research Organizations (CROs)
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | Kaori |
| Middle name | |
| Last name | Nakagawa |
Organization
Takeda Pharmaceutical Company Limited
Division name
Japan Medial Office
Zip code
103-8668
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo
TEL
03-3278-2111
kaori.nakagawa@takeda.com
Public contact
Name of contact person
| 1st name | Kiyoto |
| Middle name | |
| Last name | Naito |
Organization
Takeda Pharmaceutical Company Limited
Division name
Japan Medial Office
Zip code
103-8668
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo
TEL
03-3278-2111
Homepage URL
kiyoto.naito@takeda.com
Sponsor or person
Institute
Takeda Pharmaceutical Company Limited
Institute
Department
Personal name
Funding Source
Organization
Takeda Pharmaceutical Company Limited
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Takahashi Clinic Ethics Committee
Address
1F, Medical Hat, 5-1-31 Iwayakita-machi, Nada-ku, Kobe-shi, Hyogo 657-0846
Tel
078-882-6432
kishimoto.satoshi@neues.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 05 | Month | 08 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 04 | Month | 02 | Day |
Date of IRB
| 2025 | Year | 04 | Month | 15 | Day |
Anticipated trial start date
| 2025 | Year | 05 | Month | 15 | Day |
Last follow-up date
| 2025 | Year | 05 | Month | 28 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2025 | Year | 05 | Month | 08 | Day |
Last modified on
| 2025 | Year | 05 | Month | 08 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066059
